Serena Fattori

Serena Fattori

Auto-generated profile, based on publicly available information

Serena Fattori

INFN Laboratori Nazionali del Sud, Catania, Italy

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in Journal of Instrumentation
Verified
Journal Article
Closed access
PDF file
EAE. Aprile
E. Aprile
FAF. Agostini
F. Agostini
MAM. Alfonsi
M. Alfonsi
KAK. Arisaka
K. Arisaka
FAFrancesco Arneodo
Francesco Arneodo
CWC. Weinheimer
C. Weinheimer

18 June 2024 in Medical Physics
Verified
Journal Article
Closed access
HTHoang Tran
Hoang Tran
JAJay Archer
Jay Archer
GBGérard Baldacchino
Gérard Baldacchino
JBJeremy M. C. Brown
Jeremy M. C. Brown
FCFlore Chappuis
Flore Chappuis
SISebastien Incerti
Sebastien Incerti

21 February 2025 in Medical Physics
Verified
Journal Article
Open access
PAPedro Arce
Pedro Arce
JAJay W. Archer
Jay W. Archer
LALorenzo Arsini
Lorenzo Arsini
ABAlexander Bagulya
Alexander Bagulya
DBDavid Bolst
David Bolst
DWDennis H. Wright
Dennis H. Wright
Background: Geant4, a Monte Carlo Simulation Toolkit extensively used in bio‐medical physics, is in continuous evolution to include newest research findings to improve its accuracy and to respond to the evolving needs of a very diverse user community. In 2014, the G4‐Med benchmarking system was born from the effort of the Geant4 Medical Simulation Benchmarking Group, to benchmark and monitor the evolution of Geant4 for medical physics applications. The G4‐Med system was first described in our Medical Physics Special Report published in 2021. Results of the tests were reported for Geant4 10.5. Purpose: In this work, we describe the evolution of the G4‐Med benchmarking system. Methods: The G4‐Med benchmarking suite currently includes 23 tests, which benchmark Geant4 from the calculation of basic physical quantities to the simulation of more clinically relevant set‐ups. New tests concern the benchmarking of Geant4‐DNA physics and chemistry components for regression testing purposes, dosimetry for brachytherapy with a source, dosimetry for external x‐ray and electron FLASH radiotherapy, experimental microdosimetry for proton therapy, and in vivo PET for carbon and oxygen beams. Regression testing has been performed between Geant4 10.5 and 11.1. Finally, a simple Geant4 simulation has been developed and used to compare Geant4 EM physics constructors and physics lists in terms of execution times. Results: In summary, our EM tests show that the parameters of the multiple scattering in the Geant4 EM constructor G4EmStandardPhysics_option3 in Geant4 11.1, while improving the modeling of the electron backscattering in high atomic number targets, are not adequate for dosimetry for clinical x‐ray and electron beams. Therefore, these parameters have been reverted back to those of Geant4 10.5 in Geant4 11.2.1. The x‐ray radiotherapy test shows significant differences in the modeling of the bremsstrahlung process, especially between G4EmPenelopePhysics and the other constructors under study ( G4EmLivermorePhysics , G4EmStandardPhysics_option3 , and G4EmStandardPhysics_option4 ). These differences will be studied in an in‐depth investigation within our Group. Improvement in Geant4 11.1 has been observed for the modeling of the proton and carbon ion Bragg peak with energies of clinical interest, thanks to the adoption of ICRU90 to calculate the low energy proton stopping powers in water and of the Linhard–Sorensen ion model, available in Geant4 since version 11.0. Nuclear fragmentation tests of interest for carbon ion therapy show differences between Geant4 10.5 and 11.1 in terms of fragment yields. In particular, a higher production of boron fragments is observed with Geant4 11.1, leading to a better agreement with reference data for this fragment. Conclusions: Based on the overall results of our tests, we recommend to use G4EmStandardPhysics_option4 as EM constructor and QGSP_BIC_HP with G4EmStandardPhysics_option4 , for hadrontherapy applications. The Geant4‐DNA physics lists report differences in modeling electron interactions in water, however, the tests have a pure regression testing purpose so no recommendation can be formulated.

18 January 2012 in Physical Review D
Verified
Journal Article
Closed access
PDF file
EAE. Aprile
E. Aprile
KAK. Arisaka
K. Arisaka
FAFrancesco Arneodo
Francesco Arneodo
AAA. Askin
A. Askin
LBL. Baudis
L. Baudis
CWC. Weinheimer
C. Weinheimer
DOI:https://doi.org/10.1103/PhysRevD.85.029904

5 August 2022 in Physics in Medicine & Biology
Verified
Journal Article
Closed access
PDF file
SFS Fattori
S Fattori
GPGiada Petringa
Giada Petringa
SAS Agosteo
S Agosteo
DBDavide Bortot
Davide Bortot
VCV Conte
V Conte
GCGiuseppe Pablo Cirrone
Giuseppe Pablo Cirrone
Objective. In the present hadrontherapy scenario, there is a growing interest in exploring the capabilities of different ion species other than protons and carbons. The possibility of using different ions paves the way for new radiotherapy approaches, such as the multi-ions treatment, where radiation could vary according to target volume, shape, depth and histologic characteristics of the tumor. For these reasons, in this paper, the study and understanding of biological-relevant quantities was extended for the case of 4 He ion. Approach. Geant4 Monte Carlo based algorithms for dose- and track-averaged LET (Linear Energy Transfer) calculations, were validated for 4 He ions and for the case of a mixed field characterised by the presence of secondary ions from both target and projectile fragmentation. The simulated dose and track averaged LETs were compared with the corresponding dose and frequency mean values of the lineal energy, y D ¯ and y ¯ F , derived from experimental microdosimetric spectra. Two microdosimetric experimental campaigns were carried out at the Italian eye proton therapy facility of the Laboratori Nazionali del Sud of Istituto Nazionale di Fisica Nucleare (INFN-LNS, Catania, I) using two different microdosimeters: the MicroPlus probe and the nano-TEPC (Tissue Equivalent Proportional Counter). Main results. A good agreement of L ¯ d Total and L ¯ t Total with y ¯ D and y ¯ T experimentally measured with both microdosimetric detectors MicroPlus and nano-TEPC in two configurations: full energy and modulated 4 He ion beam, was found. Significance. The results of this study certify the use of a very effective tool for the precise calculation of LET, given by a Monte Carlo approach which has the advantage of allowing detailed simulation and tracking of nuclear interactions, even in complex clinical scenarios.

26 July 2023 in Radiation Physics and Chemistry
Verified
Journal Article
Closed access
FFFateme Farokhi
Fateme Farokhi
BSBabak Shirani
Babak Shirani
SFSerena Fattori
Serena Fattori
MAMohammad Ali Asgarian
Mohammad Ali Asgarian
GCGiacomo Cuttone
Giacomo Cuttone
GCGiuseppe Pablo Cirrone
Giuseppe Pablo Cirrone